SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-019515
Filing Date
2022-05-11
Accepted
2022-05-11 16:02:42
Documents
12
Period of Report
2022-05-11
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sndx-8k_20220511.htm   iXBRL 8-K 49667
  Complete submission text file 0001564590-22-019515.txt   182851

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA sndx-20220511.xsd EX-101.SCH 5685
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE sndx-20220511_lab.xml EX-101.LAB 20183
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sndx-20220511_pre.xml EX-101.PRE 12031
6 EXTRACTED XBRL INSTANCE DOCUMENT sndx-8k_20220511_htm.xml XML 3663
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37708 | Film No.: 22913614
SIC: 2834 Pharmaceutical Preparations